【Molecular composition】：

【CAS】：100286-90-6

【source】：Irinotecan Hcl

【Certification】：China GMP、CEP

【Spec】：EP/USP/JP

【DMF】：Available

【use】：

Irinotecan Hcl is indicated for the treatment of patients with metastatic carcinoma of the 275 colon or rectum whose disease has recurred or progressed following 5-FU-based therapy.